Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer

Name: Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer
License: Public Domain

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

ClinicalTrials.gov · Datasets · License: Public Domain

resectable biliary tract cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 356462
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.